Trials / Conditions / Chronic Hepatitis Delta
Chronic Hepatitis Delta
5 registered clinical trials studyying Chronic Hepatitis Delta — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus NCT07096193 | Gilead Sciences | Phase 1 / Phase 2 |
| Withdrawn | Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis NCT05953545 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Unknown | Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta NCT04170452 | Tokhirbek Dolimov | — |
| Completed | Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Partici NCT03852433 | Gilead Sciences | Phase 2 |
| Completed | Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) NCT03852719 | Gilead Sciences | Phase 3 |